Non-reusable drug prefilled syringe assembly and method of use

• US 4,252,118 A
• Filed: 04/21/1977
• Issued: 02/24/1981
• Est. Priority Date: 04/23/1976
• Status: Expired due to Term

• Current Assignee: Claude Imbert, Jacques Richard
• Original Assignee: Claude Imbert, Jacques Richard
• Inventors: Imbert, Claude, Richard, Jacques
• Primary Examiner(s): Yasko, John D.
• Application Number:
  US05/789,624
• Time in Patent Office: 1,405 Days
• Field of Search: 128/215, 128/218 P, 128/218 PA, 128/218 N, 128/218 R, 128/2 F, 128/DIG. 5, 128/234
• US Class Current: 604/110
• CPC Class Codes: A61M 5/31 Details
• CPC Class Codes: A61M 5/50 having means for preventing re-use, or for indicating if defective, used, tampered with or unsterile retractable needles or needle protectors with means for preventing re-use A61M5/321

Abstract

A non-reusable prefilled syringe for a single administration of a drug solution. The syringe has a plunger for expelling the solution which is detachably fitted with an elastomeric cap. The syringe allows for a pre-vein test but is not adapted for reuse. A method of use for subcutaneous injection of mini-doses of the drug solution.

Claims

1. In a syringe, adapted to preclude reuse, prefilled with a drug solution, having a hollow syringe barrel with an open distal end adapted to have a needle fixed thereto in fluid communication therewith for dispensing of the drug solution contained therein through the needle, the syringe having an open rear end adapted to be sealed by an elastomeric stopper in sliding engagement with the walls of the syringe barrel, the improvement which comprises

a plunger assembly including a plunger-rod having a projection at one end, the projection comprising a reduced diameter portion terminating in a flanged tip, and the elastomeric stopper having a recess in one end thereof, the recess terminating in an enlarged flange receiving portion, wherein the diameter of the flanged tip of the projection of the rod is less than the diameter of the flange receiving portion of the recess of the stopper but greater than the diameter of the recess of the stopper, the interengaging surfaces of which are configured for releasably making engagement, and

a drug solution contained within the syringe,

wherein the plunger assembly is adapted so that the stopper is not released from the projection of the rod when limited manual withdrawal of the plunger is performed when the syringe is filled with the solution, for a vein test prior to administration of the solution of the drug to be administered, and

the stopper is disconnected from the rod, remaining in the barrel, when, after the drug has been administered, and the syringe is empty, the plunger is withdrawn within the barrel with a force equal to that necessary to aspirate a new drug solution into the syringe,

thereby rendering the syringe useless for reuse.

2. The syringe of claim 1 wherein the stopper is disconnected from the rod when, after the drug has been administered, the plunger is withdrawn within the barrel with a force greater than that necessary to aspirate a new solution into the syringe.

3. The syringe of claim 1 wherein the barrel is of a size capable of containing a 0.2 to 0.4 ml dose of the drug solution.

4. The syringe of claim 3 wherein the dosage is 5000 IU or 2500 IU.

5. The syringe of claim 3 wherein the drug solution is a heparin salt.

6. In a syringe, adapted to preclude reuse, pre-filled with a drug solution, having a hollow syringe barrel with an open distal end adapted to have a needle fixed thereto in fluid communication therewith for dispensing of the drug solution contained therein through the needle, the syringe having an open rear end adapted to be sealed by an elastomeric stopper in sliding engagement with the walls of the syringe barrel, the improvement which comprises

a plunger assembly including a plunger-rod having a projection at one end, the projection comprising a reduced diameter portion terminating in a flanged tip, and the elastomeric stopper having a recess in one end thereof, the recess terminating in an enlarged flange receiving portion, wherein the diameter of the flanged tip of the projection of the rod is less than the diameter of the flange receiving portion of the recess of the stopper but greater than the diameter of the recess of the stopper, the interengaging surfaces of which are configured for releasably making engagement, so that

the stopper is not released from the projection of the rod when limited manual withdrawal of the plunger is performed for a vein test prior to administration of the solution of the drug to be administered, and

the stopper is disconnected from the rod, remaining in the barrel, when, after the drug has been administered, the plunger is withdrawn within the barrel with a force equal to that necessary to aspirate a new solution into the syringe, thereby rendering the syringe useless for reuse.

7. The syringe of claim 6 wherein the flanged tip at the end of the projection of the rod is frustoconical.

8. The syringe of claim 6 wherein at least one end of the stopper is a closed end.

9. The syringe of claim 6 wherein the stopper has ribs which cooperate with the side of the barrel to seal the drug solution in the barrel.

10. The syringe of claim 6 wherein the stopper has a non-planar surface in contact with the drug solution.

11. The syringe of claim 10 wherein the non-planar surface is conical in shape.

12. The syringe of claim 11 wherein the conical surface of the stopper is essentially non-distorting.

13. The syringe of claim 6 wherein the edge of the stopper which is in contact with the drug solution is convex.

14. The syringe of claim 13 wherein the contacting edge of the stopper is adapted to maintain its convex shape during retraction of the plunger for the vein test.

15. The syringe of claim 7 wherein the terminating end of the enlarged flange receiving portion of the stopper is conical.

16. The syringe of claim 15 wherein the frustoconical tip of the projection of the plunger-rod contacts the conical portion of the surface of the recess at selected portions only.

17. The syringe of claim 16 wherein the frustoconical tip of the projection of the plunger-rod does not contact the apex of the conical surface portion of the recess.

18. The syringe of claim 16 wherein only the oblique face of the frustoconical tip contacts the conical surface portion of the recess of the stopper.

19. The syringe of claim 18 wherein the only portions of the projection of the plunger rod which contact the surfaces of the recess of the stopper are along the oblique face of the frustoconical tip.

20. The syringe of claim 16 wherein the end of the stopper which contacts the plunger-rod is annularly separated from the barrel of the syringe.

21. The syringe of claim 6 wherein the end of the stopper which contacts the plunger-rod is annularly separated from the barrel of the syringe.

22. The syringe of claim 9 wherein the barrel and the stopper are annularly separated from each other at more than two locations.

23. The syringe of claim 22 wherein the surfaces of the stopper along those areas of the stopper which are annularly separated from the barel are non-linear.

24. The syringe of claim 9 wherein the forwardmost end of the projection of the plunger-rod terminates at a position before that of the forwardmost rib of the stopper.

25. The syringe of claim 6 wherein the stopper is a solid, unitary structure.

26. In a syringe, adapted to preclude reuse, prefilled with a heparin salt solution, having a hollow syringe barrel with an open distal end adapted to have a needle fixed thereto in fluid communication therewith for dispensing of the drug solution contained therein through the needle, the syringe having an open rear end adapted to be sealed by an elastomeric stopper in sliding engagement with the walls of the syringe barrel,

the improvement which comprises a plunger assembly including a plunger-rod having a projection at one end, the projection comprising a reduced diameter portion terminating in a frustoconical tip, and the elastomeric stopper, which is a solid, unitary structure, having a recess in one end thereof, the recess extending into an enlarged tip receiving portion, the terminating end of which is conical,

wherein the diameter of the frustoconical tip of the projection of the rod is less than the diameter of the tip receiving portion of the recess of the stopper but greater than the diameter of the recess of the stopper,

wherein the frustoconical tip of the projection of the plunger-rod and the conical portion of the surface of the recess of the stopper are configured so that the truncated portion of the frustoconical tip does not contact the apex of the conical surface portion of the recess, and so that the oblique portions of the frustoconical tip do contact the conical surface portion of the recess,

wherein the stopper has ribs which cooperate with the sides of the barrel of the syringe to seal the drug solution in the barrel, the ribs being separated by areas which are annularly spaced away from the barrel of the syringe, the surfaces of the annular separations along the stopper being non-linear, and the end of the stopper which contacts the plunger-rod being annularly separated from the barrel of the syringe, and

wherein the interengaging surfaces of the stopper and the projection of the plunger-rod are configured so that,

the stopper is not released from the projection of the rod when limited manual withdrawal of the plunger is performed for a vein test prior to administration of the solution of the drug to be administered, and

28. The syringe of claim 26 wherein the needle is fixed inside the forward portion in close proximity to the cylinder of the syringe, thus reducing the dead space and contributing to more precise administration of the drug.

30. The syringe of claim 28 wherein the needle has a diameter of about 0.45 to 0.50 angstroms.

33. The method of claim 30 wherein the drug administered to the patient is a heparin salt, the dosage of which is about 2500 IU to 10,000 IU.

35. The method of claim 30 which further comprises performing a vein test prior to administering the solution contained in the full syringe by manually, slightly withdrawing the plunger within the barrel of the syringe, the stopper remaining attached to the plunger, and determining whether blood has thereby been aspirated into the distal end of the syringe.

36. The method of claim 30 which further comprises administering the minidose of heparin to the patient at preselected times preceeding surgery without requiring the intervention of trained medical personnel, whereby a person without medical training may perform presurgical preparation.

37. The method of claim 30 which further comprises withdrawing the plunger from the barrel and separately disposing of the plunger, whereby the stopper remains in the barrel of the syringe thus preventing reuse.

27. the stopper is disconnected from the rod, remaining in the barrel, when, after the drug has been administered, the plunger is withdrawn within the barrel with a force equal to that necessary to aspirate a new solution into the syringe, thereby rendering the syringe useless for reuse.

29. The syringe of claim 27 wherein the needle has a length of about 10 to 15 mm.

31. In a syringe, adapted to preclude reuse, prefilled with a drug solution, having a hollow syringe barrel with an open distal end adapted to have a needle fixed thereto in fluid communication therewith for dispensing of the drug solution contained therein through the needle, the syringe having an open rear end adapted to be sealed by an elastomeric stopper in sliding engagement with the walls of the syringe barrel,

the improvement which comprises a plunger assembly including a plunger-rod having a projection at one end, and the elastomeric stopper having a recess in one end thereof, and

means for releasably engaging the stopper and the projection of the plunger-rod, so that

the stopper is not released from the projection of the rod when there is performed a vein test prior to administration of the solution of the drug to be administered, and so that

the stopper must disconnect from the rod, remaining in the barrel, whenever, after the drug has been administered, the plunger is withdrawn within the barrel to aspirate a new solution into the syringe, thereby rendering the syringe useless for reuse, wherein

the engaging means comprises the projection of the plunger-rod and the recess of the stopper wherein

the projection of the plunger-rod has a reduced diameter portion which terminates in a frustoconical tip,

the recess of the stopper, which stopper is solid and unitary, extends into an enlarged tip receiving portion, the terminating end of which is conical, and

wherein the diameter of the frustoconical tip of the projection of the rod is less than the diameter of the tip receiving portion of the recess of the stopper but greater than the diameter of the recess of the stopper, and

wherein the frustoconical tip of the projection of the plunger-rod and the conical portion of the surface of the recess of the stopper are configured so that the truncated portion of the frustoconical tip does not contact the apex of the conical surface portion of the recess, and so that the oblique portions of the frustoconical tip do contact the conical surface portion of the recess.

32. A method for administering once a preselected mini-dose of a solution of heparin salt with a syringe, adapted to preclude reuse, the syringe having a hollow syringe barrel with an open distal end adapted to have a needle fixed thereto in fluid communication therewith for dispensing of the drug solution contained therein through the needle, an open rear end adapted to be sealed by an elastomeric stopper in sliding engagement with the walls of the syringe barrel, and a plunger assembly including a plunger-rod having a projection at one end, the projection comprising a reduced diameter portion terminating in a flanged tip, and the elastomeric stopper having a recess in one end thereof, the recess terminating in an enlarged flange receiving portion, wherein the diameter of the flanged tip of the projection of the rod is less than the diameter of the flange receiving portion of the recess of the stopper but greater than the diameter of the recess of the stopper, the interengaging surfaces of which are configured for releasably making engagement, so that the stopper is not released from the projection of the rod when limited manual withdrawal of the plunger is performed when the syringe is filled with the solution, for a vein test prior to administration of the solution of the drug to be administered, and the stopper is disconnected from the rod, remaining in the barrel, when the plunger is withdrawn within the barrel when the syringe is empty, after the drug has been administered, in an attempt to aspirate a new solution into the syringe, which method comprises:

administering the solution contained in the full syringe subcutaneously to the patient, and thereafter

attempting to withdraw the plunger assembly within the barrel for aspiration of a new solution into the empty syringe, while simultaneously,

disconnecting the stopper from the projection of the plunger-rod,

whereby the stopper is disconnected from the plunger-rod rendering the syringe useless for reuse.

34. The method of claim 32 wherein the dosage is 5,000 IU.